From Simon Kerry, MedCity Advisory Board member, CEO of Karus Therapeutics, and co-founder of Angels4LifeSciences
One of the four main goals of MedCity is to nurture an environment in which life science entrepreneurship can thrive. Fundamental to this goal is access to finance, and it has been my great pleasure to be part of the team delivering this aim. The establishment of Angels in MedCity has been one of the great achievements of MedCity’s first year – devised and delivered by London Business Angels in collaboration with Angels4LifeSciences and MedCity.
Since its launch in October last year, we have held three investor workshops and two presentation events for early-stage life sciences companies, bringing together over 100 people who form the foundation of a new and growing investor community focused on life science investment. Our next presentation event will take place in June, and there is still time for potential investors and emerging companies to participate.
Early stage investment in life science companies is an issue close to my heart, as CEO of a fast-growing biotech and a co-founder of Angels4LifeSciences. Securing investment for early stage life science companies is vital for the UK economy, but it has to be knowledgeable, sustainable and positive investment on the part of the angels themselves. Angels in MedCity has huge potential to tick both boxes.